Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesInflammatory, Hemostatic and Other Novel Biomarkers for Diabetic Retinopathy: The Multi-Ethnic Study of Atherosclerosis (MESA)
Diabetes Care, 07/02/09
Wong TY et al. - There were few associations of novel markers of inflammation, hemostasis and homocysteine with DR after controlling for established risk factors. These data suggest there is limited clinical use of these biomarkers for prediction of DR.
Related Articles
Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09
Relevance Score: 69%
Retinopathy - screening recommendations
Australian Family Physician, 10/06/09
Relevance Score: 69%
Ocular surface temperature in diabetic retinopathy: a pilot study by infrared thermography
European Journal of Ophthalmology, 11/11/09
Relevance Score: 67%
Micronutrients and Diabetic Retinopathy: A Systematic Review
Ophthalmology, 11/10/09
Relevance Score: 67%
Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients
Nephrology, 10/05/09
Relevance Score: 67%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/10/09
Changes in levels of haemoglobin A 1c during the first 6 years after diagnosis of clinical type 2 diabetes
Scandinavian Journal of Clinical and Laboratory Investigation, 12/10/09
Influence of BMI, Age and Duration of Diabetes Mellitus on Glycaemic Control with Twice-Daily Injections of Biphasic Insulin Aspart 30 versus Multiple Daily Injections of Insulin Aspart (JDDM 18): Retrospective Reanalysis of a 6-Month, Randomized, Open-Label, Multicentre Trial in Japan
Clinical Drug Investigation, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor